PL370080A1 - Methods for preventing and treating bone loss with steroid compounds - Google Patents

Methods for preventing and treating bone loss with steroid compounds

Info

Publication number
PL370080A1
PL370080A1 PL02370080A PL37008002A PL370080A1 PL 370080 A1 PL370080 A1 PL 370080A1 PL 02370080 A PL02370080 A PL 02370080A PL 37008002 A PL37008002 A PL 37008002A PL 370080 A1 PL370080 A1 PL 370080A1
Authority
PL
Poland
Prior art keywords
preventing
methods
bone loss
treating bone
steroid compounds
Prior art date
Application number
PL02370080A
Other languages
English (en)
Polish (pl)
Inventor
Salle Enrico Di
Giorgio Massimini
Colin Lowery
Paul Edward Goss
Original Assignee
Pharmacia Italia Spa
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa, Pharmacia & Upjohn Company filed Critical Pharmacia Italia Spa
Publication of PL370080A1 publication Critical patent/PL370080A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL02370080A 2001-10-10 2002-09-30 Methods for preventing and treating bone loss with steroid compounds PL370080A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32820901P 2001-10-10 2001-10-10

Publications (1)

Publication Number Publication Date
PL370080A1 true PL370080A1 (en) 2005-05-16

Family

ID=23279989

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370080A PL370080A1 (en) 2001-10-10 2002-09-30 Methods for preventing and treating bone loss with steroid compounds

Country Status (12)

Country Link
EP (1) EP1435967A2 (es)
JP (1) JP2005508958A (es)
KR (1) KR20050032507A (es)
CN (1) CN1713915A (es)
BR (1) BR0213162A (es)
CA (1) CA2463142A1 (es)
IL (1) IL161162A0 (es)
MX (1) MXPA04003405A (es)
NZ (1) NZ532064A (es)
PL (1) PL370080A1 (es)
WO (1) WO2003032961A2 (es)
ZA (1) ZA200402734B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053900A1 (en) * 1998-12-23 2004-03-18 Pharmacia Corporation Method of using a COX-2 inhibitor and an aromatase inhibitor as a combination therapy
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
US7332482B2 (en) 2003-09-24 2008-02-19 Bioxell S.P.A. Method for treating benign prostatic hyperplasia
EP1937251A2 (en) * 2005-04-25 2008-07-02 Pfizer Products Inc. Pharmaceutical compositions and methods comprising a combination of a selective estrogen receptor modulator and an aromatase inhibitor
ES2627692T3 (es) 2010-06-10 2017-07-31 Aragon Pharmaceuticals, Inc. Moduladores de receptores de estrógenos y usos de los mismos
WO2013090829A1 (en) 2011-12-14 2013-06-20 Aragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
PT3929196T (pt) 2013-09-24 2023-09-11 Fujifilm Corp Composição farmacêutica de um novo composto contendo azoto ou seu sal, ou seu complexo de metal
SG11201805387RA (en) 2015-12-30 2018-07-30 Univ Saint Louis Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8721384D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia 17-substituted andro-sta-1 4-dien-3-one derivatives
GB2294879A (en) * 1994-10-19 1996-05-15 Merck & Co Inc Cylcooxygenase-2 Inhibitors
US6590079B2 (en) * 1997-01-30 2003-07-08 Ixsys, Incorporated Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same
ID28460A (id) * 1998-07-08 2001-05-24 Lipogenics Inc Komposisi dan metoda untuk perlakuan dan pencegahan penyakit tulang dengan menggunakan tocotrienol
AU6567800A (en) * 1999-08-13 2001-03-13 Alfred Schmidt Substances and agents for positively influencing collagen

Also Published As

Publication number Publication date
JP2005508958A (ja) 2005-04-07
KR20050032507A (ko) 2005-04-07
CN1713915A (zh) 2005-12-28
ZA200402734B (en) 2005-01-13
WO2003032961A2 (en) 2003-04-24
WO2003032961A3 (en) 2003-09-04
EP1435967A2 (en) 2004-07-14
BR0213162A (pt) 2004-09-14
CA2463142A1 (en) 2003-04-24
MXPA04003405A (es) 2004-06-18
IL161162A0 (en) 2004-08-31
NZ532064A (en) 2006-04-28

Similar Documents

Publication Publication Date Title
IL233205B (en) Substances for the treatment or prevention of pre-eclampsia
EP1411849A4 (en) APPARATUS AND METHODS FOR TREATING TISSUE
EP1217963A4 (en) DEVICES AND METHOD FOR TREATMENT OF TISSUE
EP1446114A4 (en) COMPOSITIONS AND METHODS FOR TREATING OSTEOPOROSIS
EP1416961A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF A DISEASE
EP1200086A4 (en) THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
GB0110288D0 (en) Composition and treatment method
EP1361604A4 (en) DEVICE AND METHOD OF TREATMENT
AU2002219945A1 (en) Composition and method for treating snoring
EP1446087A4 (en) METHOD FOR TREATING NON-NEUROPATHIC PAIN
IL164219A0 (en) Method for treating and preventing hyparathyroidism
HU0200173D0 (en) Method for preventing and treating skin aging
EP1109548A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING BONE DISEASES USING TOCOTRIENOLE
EP1351647A4 (en) COMPOSITIONS AND METHODS FOR TREATING HYPERPIGMENTATION
GB2379761B (en) System and method for appliance adaptation and evolution
AU2002367023A8 (en) Compositions and methods for treating heart failure
IL161073A0 (en) Composition and method for treating diabetes
AU2002365057A8 (en) Compositions and methods for treating heart failure
IL161162A0 (en) Methods for preventing and treating bone loss with steroid compounds
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2006902A (en) Methods and instruments for treating pseudoarthrosis
AU2001218024A1 (en) Methods for treating and preventing alopecia
EP1253930A4 (en) METHODS AND COMPOSITIONS FOR TREATING HEPATOCELLULAR CANCER
AU2002352925A8 (en) Method for treating and preventing pancreatitis

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)